Drug Patents owned by Tolmar Therap

1. List of Eligard Kit drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8470359 TOLMAR THERAP Sustained release polymer
Oct, 2023

(8 months from now)

Drugs and Companies using LEUPROLIDE ACETATE ingredient

Market Authorisation Date: 24 July, 2002

Treatment: Method of treating cancer

Dosage: POWDER;SUBCUTANEOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in